1. Report Introduction 2. Graft versus host disease (GVHD) Epidemiology Overview at a Glance 2.1. Patient Share Distribution of Graft versus host disease (GVHD) in 2016 2.2. Patient Share Distribution of Graft versus host disease (GVHD) in 2028 3. Disease Background and Overview: Graft versus host disease (GVHD) 3.1. Introduction 3.2. Symptoms 3.3. Etiology 3.4. Risk Factors 3.5. Pathophysiology 3.6. Diagnosis 3.7. Treatment 4. Epidemiology and Patient Population 4.1. Key Findings 4.2. Total Prevalent/ Incident Patient Population of Graft versus host disease (GVHD) in 7MM 4.3. Total Prevalent/ Incident Patient Population of Graft versus host disease (GVHD) in 7MM – By Countries 5. Epidemiology of Graft versus host disease (GVHD) by Countries 5.1. United States 5.1.1. Assumptions and Rationale 5.1.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD) 5.1.3. Sub-Type Specific cases of the Graft versus host disease (GVHD) * 5.1.4. Sex- Specific Cases of the Graft versus host disease (GVHD)* 5.1.5. Diagnosed Cases of the Graft versus host disease (GVHD) 5.2. EU5 5.3. Assumptions and Rationale 5.4. Germany 5.4.1. Assumptions and Rationale 5.4.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD) 5.4.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)* 5.4.4. Sex- Specific Cases of the Graft versus host disease (GVHD)* 5.4.5. Diagnosed Cases of the Graft versus host disease (GVHD) 5.5. France 5.5.1. Assumptions and Rationale 5.5.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD) 5.5.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)* 5.5.4. Sex- Specific Cases of the Graft versus host disease (GVHD)* 5.5.5. Diagnosed Cases of the Graft versus host disease (GVHD) 5.6. Italy 5.6.1. Assumptions and Rationale 5.6.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD) 5.6.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)* 5.6.4. Sex- Specific Cases of the Graft versus host disease (GVHD)* 5.6.5. Diagnosed Cases of the Graft versus host disease (GVHD) 5.7. Spain 5.7.1. Assumptions and Rationale 5.7.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD) 5.7.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)* 5.7.4. Sex- Specific Cases of the Graft versus host disease (GVHD)* 5.7.5. Diagnosed Cases of the Graft versus host disease (GVHD) 5.8. United Kingdom 5.8.1. Assumptions and Rationale 5.8.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD) 5.8.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)* 5.8.4. Sex- Specific Cases of the Graft versus host disease (GVHD)* 5.8.5. Diagnosed Cases of the Graft versus host disease (GVHD) 5.9. Japan 5.9.1. Assumptions and Rationale 5.9.2. Prevalent/Incident Cases of the Graft versus host disease (GVHD) 5.9.3. Sub-Type Specific cases of the Graft versus host disease (GVHD)* 5.9.4. Sex- Specific Cases of the Graft versus host disease (GVHD)* 5.9.5. Diagnosed Cases of the Graft versus host disease (GVHD) 6. Unmet Needs of the Graft versus host disease (GVHD) 7. Appendix 8. Report Methodology 8.1. Sources 9. Capabilities 10. Disclaimer 11. About *Indication Specific

Table 1: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM Table 2: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM by Countries Table 3: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in United States (2016-2028) Table 4: Sub-Type Specific cases of the Graft versus host disease (GVHD) in United States (2016-2028)* Table 5: Sex- Specific Cases of the Graft versus host disease (GVHD) in United States (2016-2028)* Table 6: Diagnosed Cases of the Graft versus host disease (GVHD) in United States (2016-2028) Table 7: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) Table 8: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Germany (2016-2028) * Table 9: Sex- Specific Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) * Table 10: Diagnosed Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) Table 11: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in France (2016-2028) Table 12: Sub-Type Specific cases of the Graft versus host disease (GVHD) in France (2016-2028) * Table 13: Sex- Specific Cases of the Graft versus host disease (GVHD) in France (2016-2028) * Table 14: Diagnosed Cases of the Graft versus host disease (GVHD) in France (2016-2028) Table 15: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) Table 16: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Italy (2016-2028) * Table 17: Sex- Specific Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) * Table 18: Diagnosed Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) Table 19: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) Table 20: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Spain (2016-2028) * Table 21: Sex- Specific Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) * Table 22: Diagnosed Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) Table 23: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in UK (2016-2028) Table 24: Sub-Type Specific cases of the Graft versus host disease (GVHD) in UK (2016-2028) * Table 25: Sex- Specific Cases of the Graft versus host disease (GVHD) in UK (2016-2028) * Table 26: Diagnosed Cases of the Graft versus host disease (GVHD) in UK (2016-2028) Table 27: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Japan (2016-2028) Table 28: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Japan (2016-2028) * Table 29: Sex- Specific Cases of the Graft versus host disease (GVHD) in Japan (2016-2028) * Table 30: Diagnosed Cases of the Graft versus host disease (GVHD) in Japan (2016-2028) Figure 1: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM Figure 2: Total Prevalent/Incident Cases of the Graft versus host disease (GVHD) in 7MM by Countries Figure 3: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in United States (2016-2028) Figure 4: Sub-Type Specific cases of the Graft versus host disease (GVHD) in United States (2016-2028)* Figure 5: Sex- Specific Cases of the Graft versus host disease (GVHD) in United States (2016-2028)* Figure 6: Diagnosed Cases of the Graft versus host disease (GVHD) in United States (2016-2028) Figure 7: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) Figure 8: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Germany (2016-2028) * Figure 9: Sex- Specific Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) * Figure 10: Diagnosed Cases of the Graft versus host disease (GVHD) in Germany (2016-2028) Figure 11: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in France (2016-2028) Figure 12: Sub-Type Specific cases of the Graft versus host disease (GVHD) in France (2016-2028) * Figure 13: Sex- Specific Cases of the Graft versus host disease (GVHD) in France (2016-2028) * Figure 14: Diagnosed Cases of the Graft versus host disease (GVHD) in France (2016-2028) Figure 15: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) Figure 16: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Italy (2016-2028) * Figure 17: Sex- Specific Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) * Figure 18: Diagnosed Cases of the Graft versus host disease (GVHD) in Italy (2016-2028) Figure 19: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) Figure 20: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Spain (2016-2028) * Figure 21: Sex- Specific Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) * Figure 22: Diagnosed Cases of the Graft versus host disease (GVHD) in Spain (2016-2028) Figure 23: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in UK (2016-2028) Figure 24: Sub-Type Specific cases of the Graft versus host disease (GVHD) in UK (2016-2028) * Figure 25: Sex- Specific Cases of the Graft versus host disease (GVHD) in UK (2016-2028) * Figure 26: Diagnosed Cases of the Graft versus host disease (GVHD) in UK (2016-2028) Figure 27: Prevalent/Incident Cases of the Graft versus host disease (GVHD) in Japan (2016-2028) Figure 28: Sub-Type Specific cases of the Graft versus host disease (GVHD) in Japan (2016-2028) * Figure 29: Sex- Specific Cases of the Graft versus host disease (GVHD) in Japan (2016-2028) * Figure 30: Diagnosed Cases of the Graft versus host disease (GVHD) in Japan (2016-2028)